Loxo Oncology (LOXO) Share Value Rose While Opaleye Management Has Boosted by $3.89 Million Its Stake; Marketfield Asset Management Has Increased Intuitive Surgical (ISRG) Position by $6.33 Million

April 20, 2018 - By wolcottdaily

Intuitive Surgical, Inc. (NASDAQ:ISRG) Logo

James A. Silverman increased its stake in Loxo Oncology (LOXO) by 35.62% based on its latest 2017Q4 regulatory filing with the SEC. Opaleye Management Inc bought 46,300 shares as the company’s stock rose 30.92% while stock markets declined. The hedge fund run by James A. Silverman held 176,300 shares of the health care company at the end of 2017Q4, valued at $14.84M, up from 130,000 at the end of the previous reported quarter. Opaleye Management Inc who had been investing in Loxo Oncology for a number of months, seems to be bullish on the $3.99 billion market cap company. The stock decreased 0.41% or $0.55 during the last trading session, reaching $132.9. About 112,637 shares traded. Loxo Oncology, Inc. (NASDAQ:LOXO) has risen 146.80% since April 20, 2017 and is uptrending. It has outperformed by 135.25% the S&P500.

Marketfield Asset Management Llc increased its stake in Intuitive Surgical Inc (ISRG) by 178.38% based on its latest 2017Q4 regulatory filing with the SEC. Marketfield Asset Management Llc bought 17,399 shares as the company’s stock rose 11.58% while stock markets declined. The institutional investor held 27,153 shares of the health care company at the end of 2017Q4, valued at $9.91 million, up from 9,754 at the end of the previous reported quarter. Marketfield Asset Management Llc who had been investing in Intuitive Surgical Inc for a number of months, seems to be bullish on the $51.60 billion market cap company. The stock decreased 1.37% or $6.33 during the last trading session, reaching $456.38. About 954,967 shares traded or 11.67% up from the average. Intuitive Surgical, Inc. (NASDAQ:ISRG) has risen 58.43% since April 20, 2017 and is uptrending. It has outperformed by 46.88% the S&P500.

Among 11 analysts covering Loxo Oncology Inc (NASDAQ:LOXO), 10 have Buy rating, 1 Sell and 0 Hold. Therefore 91% are positive. Loxo Oncology Inc had 36 analyst reports since July 29, 2015 according to SRatingsIntel. The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) has “Buy” rating given on Tuesday, August 8 by Stifel Nicolaus. The stock has “Overweight” rating by Morgan Stanley on Friday, October 6. As per Wednesday, December 20, the company rating was maintained by BTIG Research. Oppenheimer initiated Loxo Oncology, Inc. (NASDAQ:LOXO) rating on Thursday, February 22. Oppenheimer has “Buy” rating and $132.0 target. Citigroup maintained the stock with “Buy” rating in Friday, October 20 report. The rating was maintained by Stifel Nicolaus on Wednesday, March 16 with “Buy”. The firm has “Buy” rating by Citigroup given on Thursday, November 16. The rating was maintained by Oppenheimer on Tuesday, August 4 with “Buy”. The stock of Loxo Oncology, Inc. (NASDAQ:LOXO) earned “Buy” rating by Citigroup on Friday, January 15. BTIG Research maintained Loxo Oncology, Inc. (NASDAQ:LOXO) rating on Monday, June 5. BTIG Research has “Buy” rating and $7500 target.

Since December 8, 2017, it had 0 buys, and 16 selling transactions for $70.72 million activity. $1.22M worth of Loxo Oncology, Inc. (NASDAQ:LOXO) was sold by Bilenker Joshua H. on Thursday, December 14. Burstein Jennifer sold $223,262 worth of Loxo Oncology, Inc. (NASDAQ:LOXO) on Tuesday, March 13. Bonita David P sold $20.63M worth of stock. $1.50M worth of Loxo Oncology, Inc. (NASDAQ:LOXO) was sold by Naider Avi Z.. The insider Van Naarden Jacob sold 3,082 shares worth $271,866. ORBIMED ADVISORS LLC sold $20.63M worth of stock.

Investors sentiment decreased to 0.97 in 2017 Q4. Its down 0.76, from 1.73 in 2017Q3. It dived, as 29 investors sold LOXO shares while 43 reduced holdings. 23 funds opened positions while 47 raised stakes. 124.82 million shares or 329.48% more from 29.06 million shares in 2017Q3 were reported. Moreover, New York State Common Retirement Fund has 0% invested in Loxo Oncology, Inc. (NASDAQ:LOXO) for 24,300 shares. 106,021 are owned by Goldman Sachs Gp Incorporated. Vanguard Group Inc Inc owns 0.01% invested in Loxo Oncology, Inc. (NASDAQ:LOXO) for 1.97M shares. Gam Holdings Ag holds 55,600 shares or 0.14% of its portfolio. Credit Suisse Ag accumulated 118,061 shares. Deutsche Bancorporation Ag stated it has 128,669 shares. Employees Retirement Association Of Colorado stated it has 1,179 shares. Tocqueville Asset Mgmt Lp owns 4,000 shares or 0% of their US portfolio. Opus Point Prns Management Ltd invested in 1.01% or 13,800 shares. Virtu Finance Ltd reported 10,109 shares stake. Amer Intl Grp accumulated 15,398 shares. Franklin Res Incorporated reported 0.02% in Loxo Oncology, Inc. (NASDAQ:LOXO). Td Asset Mngmt owns 29,310 shares for 0% of their portfolio. Bancshares Of Ny Mellon owns 0% invested in Loxo Oncology, Inc. (NASDAQ:LOXO) for 105,231 shares. 4,692 were reported by Denver Inv Advsrs Ltd Liability Corporation.

Among 20 analysts covering Intuitive Surgical Inc (NASDAQ:ISRG), 14 have Buy rating, 1 Sell and 5 Hold. Therefore 70% are positive. Intuitive Surgical Inc had 70 analyst reports since July 22, 2015 according to SRatingsIntel. Piper Jaffray maintained the shares of ISRG in report on Thursday, July 20 with “Hold” rating. The stock has “Buy” rating by Citigroup on Thursday, November 12. On Wednesday, October 19 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. On Friday, October 20 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock has “Buy” rating by Goldman Sachs on Thursday, November 16. The stock of Intuitive Surgical, Inc. (NASDAQ:ISRG) has “Buy” rating given on Wednesday, October 19 by Canaccord Genuity. The rating was maintained by Morgan Stanley on Tuesday, July 25 with “Overweight”. The firm earned “Hold” rating on Tuesday, July 18 by RBC Capital Markets. Bank of America maintained Intuitive Surgical, Inc. (NASDAQ:ISRG) rating on Wednesday, April 20. Bank of America has “Buy” rating and $750 target. Canaccord Genuity maintained Intuitive Surgical, Inc. (NASDAQ:ISRG) rating on Wednesday, July 20. Canaccord Genuity has “Buy” rating and $750 target.

Since October 24, 2017, it had 0 buys, and 22 insider sales for $66.94 million activity. Shares for $3.20 million were sold by GUTHART GARY S. Shares for $3.34M were sold by Brogna Salvatore on Thursday, March 1. MOHR MARSHALL sold $3.11 million worth of stock or 7,500 shares. $10.39 million worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) was sold by MELTZER MARK J. $580,535 worth of Intuitive Surgical, Inc. (NASDAQ:ISRG) shares were sold by Samath Jamie. 18,000 shares valued at $6.71M were sold by SMITH LONNIE M on Tuesday, October 24.

Investors sentiment increased to 12.48 in Q4 2017. Its up 11.44, from 1.04 in 2017Q3. It is positive, as 23 investors sold ISRG shares while 21 reduced holdings. 91 funds opened positions while 458 raised stakes. 191.92 million shares or 430.23% more from 36.20 million shares in 2017Q3 were reported. Gulf Bank (Uk) Limited has invested 0.17% in Intuitive Surgical, Inc. (NASDAQ:ISRG). Carmignac Gestion holds 597,009 shares. Moreover, Highland Cap Management Lc has 0.03% invested in Intuitive Surgical, Inc. (NASDAQ:ISRG) for 1,247 shares. Maverick Cap Ltd invested in 27,020 shares or 0.12% of the stock. M&T Bank accumulated 0.05% or 26,610 shares. Atlantic Tru Grp Ltd reported 224,697 shares. Highbridge Mgmt Lc stated it has 732 shares. 1,524 were accumulated by Columbia Prtnrs L L C Mngmt. Brown Brothers Harriman And holds 808 shares or 0% of its portfolio. Retirement Systems Of Alabama invested in 54,300 shares or 0.1% of the stock. Cibc Asset Mgmt Inc owns 16,467 shares or 0.04% of their US portfolio. Eagle Asset Mngmt accumulated 0.22% or 109,337 shares. Fiduciary reported 569 shares. The Arizona-based Dynamic Solutions Limited Liability Company has invested 0.27% in Intuitive Surgical, Inc. (NASDAQ:ISRG). Tower Cap Ltd Com (Trc) holds 1,885 shares.

Intuitive Surgical, Inc. (NASDAQ:ISRG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: